Paliperidone palmitate

Paliperidone palmitate is a long-acting injectable atypical antipsychotic used for the treatment of schizophrenia and schizoaffective disorder. It is an ester prodrug of paliperidone that slowly releases the active drug after intramuscular injection, providing sustained dopamine (D₂) and serotonin (5-HT₂A) receptor blockade. It is grouped under the following drug class(es): Mood stabilizers and Psychotropic agents. Its therapeutic use is listed as central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Invega Sustenna, xeplion and Invega Trinza. Its PubChem CID is 9852746.

CAS No 199739-10-1
Molecular Formula C39H57FN4O4
Molecular Weight 664.9 g/mol
Synonyms [3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-9-yl] hexadecanoate

Frequently Asked Questions